Assessing Novanta (NOVT) Valuation After A Sharp Short Term Share Price Run

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St.

Understanding Novanta after its recent share move

Novanta (NOVT) has drawn investor attention after a recent share price move, prompting a closer look at how the company’s current fundamentals line up with its recent market performance.

See our latest analysis for Novanta.

Novanta’s recent share price move comes after a strong run, with a 30 day share price return of 24.6% and a year to date share price return of 43.36%. The 1 year total shareholder return is 28.68%, but the 3 year total shareholder return has declined 6.15%, suggesting momentum has picked up recently after a weaker multi year stretch.

If you are comparing Novanta’s recent move with other areas of the market, this could be a good time to see what else is gaining attention through our screener of 33 robotics and automation stocks

With Novanta trading at $159.33 against an analyst price target of $171.50 and an intrinsic estimate that sits far above today’s level, should you see this as a mispriced opportunity or a sign that markets are already banking on future growth?

Most Popular Narrative: 2% Overvalued

The most widely followed narrative puts Novanta’s fair value at $157, slightly below the last close of $159.33, so the story hinges on execution rather than a wide discount.

The company's active pipeline of acquisitions, supported by a robust balance sheet and increased credit facility, is allowing it to continually enter new high-growth, niche markets and increase its share of recurring, software-driven revenue, catalyzing long-term revenue growth and reducing earnings volatility.

Read the complete narrative.

Want to see what powers that valuation call? The narrative leans heavily on a specific revenue glide path and a sharp margin reset, then layers on an ambitious future earnings multiple.

Result: Fair Value of $157 (OVERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, this narrative can weaken if organic growth remains muted and if trade or tariff issues, including exposure to China, continue to pressure margins and cash flow.

Find out about the key risks to this Novanta narrative.

Next Steps

With the story split between concerns and optimism, this is a moment to look at the numbers yourself and decide where you stand quickly. To see both sides set out clearly, review the 1 key reward and 1 important warning sign

Looking for more investment ideas?

If you stop with just one stock, you may miss other opportunities that better fit your goals, so put the screener to work and compare options side by side.

Story Continues

Spot potential value bargains early by scanning our list of 46 high quality undervalued stocks that pair quality fundamentals with compressed expectations. Prioritise resilience by checking out 64 resilient stocks with low risk scores that score well on stability and are designed to limit unwelcome surprises. Hunt for future standouts before they hit everyone's radar by reviewing the screener containing 22 high quality undiscovered gems built around strong underlying business quality.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include NOVT.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments